AstraZeneca, Sanofi’s RSV therapy Beyfortus for infants shows ‘protection’ in trial Finances February 21, 2023 BeritK AstraZeneca (NASDAQ:AZN) and Sanofi’s (NASDAQ:SNY) antibody remedy Beyfortus continues to indicate constant safety towards Respiratory Syncytial Virus (RSV) illness…
AstraZeneca, Biogen, Bristol, and Eli Lilly among companies w/ blockbuster potential drugs Finances January 22, 2023 Oleg Elkov/iStock by way of Getty Pictures Taking a look at just lately accredited medicine and the pipelines of main…
AstraZeneca, Alvogen fined in South Korea over alleged stalling of generic cancer drug Finances October 14, 2022 Roland Magnusson/iStock Editorial through Getty Photographs South Korea’s Truthful Commerce Fee (FTC) fined AstraZeneca (NASDAQ:AZN) and Alvogen 2.6B Korean gained…
AstraZeneca Imfinzi/tremelimumab shows survival benefit in lung cancer in 4-year data Finances September 12, 2022 Lisa Maree Williams AstraZeneca (NASDAQ:AZN) stated ~4 years of follow-up knowledge from a part 3 trial advised {that a} restricted…
